Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Filings indexed 250 across all filing types
Latest filing 2026-03-13 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 304840

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시) (제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '증권 발행결과' (Securities Issuance Result) regarding a third-party paid-in capital increase (유상증자). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2026-03-13 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a decision on a paid-in capital increase (유상증자결정) by PeopleBio. It details the correction of a previous filing, specifically adjusting the number of new shares and the purpose of the funds due to partial non-payment. This document falls under the category of announcements regarding new share issues or capital changes, which is classified as 'SHA'.
2026-03-13 Korean
불성실공시법인지정 (공시번복 2건)
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from the KOSDAQ market regarding the designation of 'PeopleBio' as an unfaithful disclosure corporation due to the cancellation of previous disclosures (capital increase and management change). This is a formal regulatory notice regarding compliance and market sanctions, which fits the 'Regulatory Filings' (RNS) category as it does not fall into specific categories like legal proceedings or financial reports.
2026-03-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea under the Capital Markets Act. This type of filing is used to disclose significant changes in share ownership (often referred to as a 5% rule filing). In the provided taxonomy, 'Major Shareholding Notification' (MRQ) is the correct category for filings that report changes in significant share ownership levels or crossing thresholds.
2026-03-04 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) for PeopleBio. It details the amendment of payment dates and listing dates for a third-party capital increase. This falls under the category of announcements regarding new share issues or capital changes.
2026-02-13 Korean
불성실공시법인지정예고 (공시번복 2건)
Regulatory Filings Classification · 95% confidence The document is a formal notice from the KOSDAQ market regarding the 'designation of an unfaithful disclosure corporation' (불성실공시법인지정예고) due to the cancellation of previous disclosures (capital increase and management change). This is a regulatory announcement concerning compliance and potential penalties, which falls under the category of regulatory filings.
2026-02-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.